The Safety of Oral Apixaban (Eliquis) Versus Subcutaneous Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy; a Prospective Randomized Open Blinded End-point (PROBE) Design
Phase of Trial: Phase II
Latest Information Update: 05 May 2017
At a glance
- Drugs Apixaban (Primary) ; Enoxaparin sodium
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 01 May 2017 Planned number of patients changed from 400 to 171.
- 01 May 2017 Planned End Date changed from 1 Jun 2018 to 1 Mar 2018.
- 19 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Jun 2018.